BeOne Medicines (BEIGF) Change in Inventory (2017 - 2026)

BeOne Medicines (BEIGF) has 10 years of Change in Inventory data on file, last reported at $71.8 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at $71.8 million, up 1901.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $169.0 million (up 236.34% YoY), and the FY2025 annual result was $93.2 million, up 1.83% from the prior year.
• Change in Inventory grew to $71.8 million in Q1 2026 per BEIGF's latest filing, from $70.5 million in the prior quarter.
• Over five years, Change in Inventory peaked at $88.6 million in Q4 2023 and troughed at -$23.8 million in Q3 2024.
• A 5-year average of $26.7 million and a median of $28.6 million in 2022 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2024 and 2026: Change in Inventory sank 1842.71% in 2024, then surged 1901.81% in 2026.
• A 5-year view of Change in Inventory shows it stood at -$18.9 million in 2022, then surged by 567.6% to $88.6 million in 2023, then dropped by 10.38% to $79.4 million in 2024, then slipped by 11.18% to $70.5 million in 2025, then grew by 1.89% to $71.8 million in 2026.
• Business Quant data shows BEIGF's Change in Inventory at $71.8 million in Q1 2026, $70.5 million in Q4 2025, and $28.8 million in Q3 2025.